Can we stop mass drug administration prior to 3 annual rounds in communities with low prevalence of trachoma?: PRET Ziada trial results
Author
Jithin Yohannan
Application Date
13-2012 Spring
Program
GHFRA
Mentor
Sheila K. West
Jithin Yohannan
13-2012 Spring
GHFRA
Sheila K. West
| « |
October 2020 |
» | ||||
|---|---|---|---|---|---|---|
S |
M |
T |
W |
T |
F |
S |
|
·
|
·
|
·
|
·
|
1 |
2 |
3 |
4 |
5 |
6 |
8 |
9 |
10 |
|
11 |
12 |
13 |
14 |
16 |
17 |
|
18 |
20 |
21 |
22 |
23 |
24 |
|
25 |
26 |
27 |
28 |
29 |
30 |
31 |
CWH researchers are using polymerase chain reaction and mass spectrometry technologies to develop a microbial isolation and...
Read More"Poshan", which means good nutrition in Nepali is ongoing research that involves two interlinked large-scale research studies...
Read MoreThis project, now in its second phase, aims to create an enabling environment for vaccines in India and contribute to...
Read More